STOCK TITAN

IBEX SEC Filings, Sep 15-16, 2026

IBEX NASDAQ
Rhea-AI Summary

IBEX Ltd (IBEX) reported that Chief Sales/Marketing Officer Julie K. Casteel sold 17,474 Common Shares on September 15, 2026 in an open-market or private transaction at a weighted average price of $40.41 per share. After this sale, she directly holds 100,814 Common Shares. No Rule 10b5-1 trading plan is reported for this transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.27%
Tags
insider
-
Rhea-AI Summary

IBEX Ltd (IBEX) reported that its Chief Legal Officer, Christina Alice Trofimuk-O'Connor, sold a total of 9,876 Common Shares in open-market or private transactions over two days. On September 15, 2026, she sold 7,500 shares at a weighted average price of $40.3002 per share, executed in multiple trades at prices ranging from $40.25 to $40.41.

On September 16, 2026, she sold an additional 2,376 shares at a weighted average price of $39.3419 per share, in multiple trades at prices ranging from $39.34 to $39.43. No Rule 10b5-1 trading plan is reported, and post-transaction share holdings are not stated in this filing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.27%
Tags
insider
-
Rhea-AI Summary

IBEX Ltd (IBEX) reports that Chief Executive Officer and director Robert Thomas Dechant sold 25,000 Common Shares on September 15, 2026 in an open-market or private transaction at a weighted average price of $39.9867 per share, and now directly holds 262,011 Common Shares. No Rule 10b5-1 trading plan is reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.27%
Tags
insider
Rhea-AI Summary

IBEX Ltd (IBEX) director Zhuang Mingzhe reported selling 5,522 common shares on September 15, 2026 in an open-market or private transaction at a weighted average price of $40.10 per share, with individual trade prices ranging from $39.82 to $40.39. After this sale, Zhuang held 2,813 common shares directly. No Rule 10b5-1 trading plan is reported for this transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.27%
Tags
insider
-
Rhea-AI Summary

IBEX Ltd (IBEX) reported that Chief People Officer Paul Joseph Inson sold 2,500 Common Shares on September 16, 2026 in an open-market or private transaction at a weighted average price of $40.0658 per share, with individual trade prices ranging from $40.04 to $40.09. Following this sale, he directly holds 27,224 Common Shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.27%
Tags
insider
-
Rhea-AI Summary

IBEX Ltd (IBEX) received a notice that affiliate Paul Inson, acting through J.P. Morgan Securities LLC as agent, plans to sell 2,500 shares of common stock under Rule 144. The shares relate to equity compensation (PSU vesting dated February 6, 2026). In the prior three months, Inson reported selling 2,274 common shares on September 14, 2026. The filing lists 13,389,116 common shares outstanding and an estimated value of $100,164.50 for the planned 2,500-share sale, with trading on NASDAQ.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.27%
Tags
other
Rhea-AI Summary

IBEX Ltd (IBEX) is the issuer of common stock for which affiliate Christina Alice Trofimuk O'Connor has filed a notice of proposed sale under Rule 144. The notice covers the planned sale of 2,376 shares of IBEX common stock through J.P. Morgan Securities LLC on NASDAQ as of September 16, 2026, with an aggregate market value of $93,476.34. IBEX common shares outstanding are reported as 13,389,116 as of that date; this is a baseline figure, not the amount being offered. The notice also reports that O'Connor sold 7,500 shares of IBEX common stock in the prior three months for proceeds of $302,251.82.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.27%
Tags
other
-
Rhea-AI Summary

IBEX Ltd (symbol IBEX) is the issuer for a notice filed on behalf of shareholder Mingzhe Zhuang to permit a potential sale of IBEX common stock under Rule 144. The notice references 5,522 shares of common stock to be sold through J.P. Morgan Securities LLC on NASDAQ, with an aggregate market value of $221,444.17 and 13,389,116 shares of common stock outstanding. The filing also lists multiple IBEX equity compensation awards, including restricted stock units (RSUs) and performance stock units (PSUs) vesting between April 1, 2025 and July 1, 2026, with individual vesting amounts ranging from 625 to 1,252 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

IBEX Ltd (IBEX) disclosed that Chief Operating Officer David Martin Afdahl sold 10,819 common shares on September 14, 2026 at a weighted average price of $40.07 per share, in transactions reported as made under a Rule 10b5-1 plan dated June 8, 2026. Following these sales, he directly holds 129,187 common shares of IBEX.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

IBEX Ltd (IBEX) reported that Chief People Officer Paul Joseph Inson sold 2,274 Common Shares on September 14, 2026 at $40.00 per share in an open-market or private transaction. The sale was made pursuant to a Rule 10b5-1 trading plan dated December 16, 2025, and left him holding 29,724 shares directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many IBEX (IBEX) SEC filings are available on StockTitan?

StockTitan tracks 157 SEC filings for IBEX (IBEX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for IBEX (IBEX)?

The most recent SEC filing for IBEX (IBEX) was filed on September 16, 2026.